BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 31503409)

  • 21. Schizophrenia susceptibility alleles are enriched for alleles that affect gene expression in adult human brain.
    Richards AL; Jones L; Moskvina V; Kirov G; Gejman PV; Levinson DF; Sanders AR; ; ; Purcell S; Visscher PM; Craddock N; Owen MJ; Holmans P; O'Donovan MC
    Mol Psychiatry; 2012 Feb; 17(2):193-201. PubMed ID: 21339752
    [TBL] [Abstract][Full Text] [Related]  

  • 22. GWAS-identified schizophrenia risk SNPs at TSPAN18 are highly diverged between Europeans and East Asians.
    Liu J; Li M; Su B
    Am J Med Genet B Neuropsychiatr Genet; 2016 Dec; 171(8):1032-1040. PubMed ID: 27312590
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Meta-analysis for genome-wide association study identifies multiple variants at the BIN1 locus associated with late-onset Alzheimer's disease.
    Hu X; Pickering E; Liu YC; Hall S; Fournier H; Katz E; Dechairo B; John S; Van Eerdewegh P; Soares H;
    PLoS One; 2011 Feb; 6(2):e16616. PubMed ID: 21390209
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Shared genetic etiology underlying Alzheimer's disease and type 2 diabetes.
    Hao K; Di Narzo AF; Ho L; Luo W; Li S; Chen R; Li T; Dubner L; Pasinetti GM
    Mol Aspects Med; 2015; 43-44():66-76. PubMed ID: 26116273
    [TBL] [Abstract][Full Text] [Related]  

  • 25. On the identification of potential regulatory variants within genome wide association candidate SNP sets.
    Chen CY; Chang IS; Hsiung CA; Wasserman WW
    BMC Med Genomics; 2014 Jun; 7():34. PubMed ID: 24920305
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Functional genetic variation at the NRGN gene and schizophrenia: evidence from a gene-based case-control study and gene expression analysis.
    Ohi K; Hashimoto R; Yasuda Y; Fukumoto M; Yamamori H; Umeda-Yano S; Okada T; Kamino K; Morihara T; Iwase M; Kazui H; Numata S; Ikeda M; Ohnuma T; Iwata N; Ueno S; Ozaki N; Ohmori T; Arai H; Takeda M
    Am J Med Genet B Neuropsychiatr Genet; 2012 Jun; 159B(4):405-13. PubMed ID: 22461181
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A common haplotype lowers PU.1 expression in myeloid cells and delays onset of Alzheimer's disease.
    Huang KL; Marcora E; Pimenova AA; Di Narzo AF; Kapoor M; Jin SC; Harari O; Bertelsen S; Fairfax BP; Czajkowski J; Chouraki V; Grenier-Boley B; Bellenguez C; Deming Y; McKenzie A; Raj T; Renton AE; Budde J; Smith A; Fitzpatrick A; Bis JC; DeStefano A; Adams HHH; Ikram MA; van der Lee S; Del-Aguila JL; Fernandez MV; Ibañez L; ; ; Sims R; Escott-Price V; Mayeux R; Haines JL; Farrer LA; Pericak-Vance MA; Lambert JC; van Duijn C; Launer L; Seshadri S; Williams J; Amouyel P; Schellenberg GD; Zhang B; Borecki I; Kauwe JSK; Cruchaga C; Hao K; Goate AM
    Nat Neurosci; 2017 Aug; 20(8):1052-1061. PubMed ID: 28628103
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inferring the Molecular Mechanisms of Noncoding Alzheimer's Disease-Associated Genetic Variants.
    Amlie-Wolf A; Tang M; Way J; Dombroski B; Jiang M; Vrettos N; Chou YF; Zhao Y; Kuzma A; Mlynarski EE; Leung YY; Brown CD; Wang LS; Schellenberg GD
    J Alzheimers Dis; 2019; 72(1):301-318. PubMed ID: 31561366
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selecting Closely-Linked SNPs Based on Local Epistatic Effects for Haplotype Construction Improves Power of Association Mapping.
    Liu F; Schmidt RH; Reif JC; Jiang Y
    G3 (Bethesda); 2019 Dec; 9(12):4115-4126. PubMed ID: 31604824
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genome-wide significant, replicated and functional risk variants for Alzheimer's disease.
    Guo X; Qiu W; Garcia-Milian R; Lin X; Zhang Y; Cao Y; Tan Y; Wang Z; Shi J; Wang J; Liu D; Song L; Xu Y; Wang X; Liu N; Sun T; Zheng J; Luo J; Zhang H; Xu J; Kang L; Ma C; Wang K; Luo X
    J Neural Transm (Vienna); 2017 Nov; 124(11):1455-1471. PubMed ID: 28770390
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic risk for Alzheimer's disease is concentrated in specific macrophage and microglial transcriptional networks.
    Tansey KE; Cameron D; Hill MJ
    Genome Med; 2018 Feb; 10(1):14. PubMed ID: 29482603
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of SOX11 Polymorphisms in distal 3'UTR with Susceptibility for Schizophrenia.
    Sun CP; Sun D; Luan ZL; Dai X; Bie X; Ming WH; Sun XW; Huo XX; Lu TL; Zhang D
    J Clin Lab Anal; 2020 Aug; 34(8):e23306. PubMed ID: 32207210
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNAs and target site screening reveals a pre-microRNA-30e variant associated with schizophrenia.
    Xu Y; Li F; Zhang B; Zhang K; Zhang F; Huang X; Sun N; Ren Y; Sui M; Liu P
    Schizophr Res; 2010 Jun; 119(1-3):219-27. PubMed ID: 20347265
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association studies testing for risk for late-onset Alzheimer's disease with common variants in the beta-amyloid precursor protein (APP).
    Nowotny P; Simcock X; Bertelsen S; Hinrichs AL; Kauwe JS; Mayo K; Smemo S; Morris JC; Goate A
    Am J Med Genet B Neuropsychiatr Genet; 2007 Jun; 144B(4):469-74. PubMed ID: 17427190
    [TBL] [Abstract][Full Text] [Related]  

  • 35.
    Cannon ME; Duan Q; Wu Y; Zeynalzadeh M; Xu Z; Kangas AJ; Soininen P; Ala-Korpela M; Civelek M; Lusis AJ; Kuusisto J; Collins FS; Boehnke M; Tang H; Laakso M; Li Y; Mohlke KL
    G3 (Bethesda); 2017 Sep; 7(9):3217-3227. PubMed ID: 28754724
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Data mining of high density genomic variant data for prediction of Alzheimer's disease risk.
    Briones N; Dinu V
    BMC Med Genet; 2012 Jan; 13():7. PubMed ID: 22273362
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of quantitative trait loci methods: Total expression and allelic imbalance method in brain RNA-seq.
    Gådin JR; Buil A; Colantuoni C; Jaffe AE; Nielsen J; Shin JH; Hyde TM; Kleinman JE; ; Plath N; Eriksson P; Brunak S; Didriksen M; Weinberger DR; Folkersen L
    PLoS One; 2019; 14(6):e0217765. PubMed ID: 31206532
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interpreting coronary artery disease GWAS results: A functional genomics approach assessing biological significance.
    Hartmann K; Seweryn M; Sadee W
    PLoS One; 2022; 17(2):e0244904. PubMed ID: 35192625
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Validating GWAS-Identified Risk Loci for Alzheimer's Disease in Han Chinese Populations.
    Wang HZ; Bi R; Hu QX; Xiang Q; Zhang C; Zhang DF; Zhang W; Ma X; Guo W; Deng W; Zhao L; Ni P; Li M; Fang Y; Li T; Yao YG
    Mol Neurobiol; 2016 Jan; 53(1):379-390. PubMed ID: 25452228
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Brain derived neurotrophic factor (BDNF) gene variants and Alzheimer's disease, affective disorders, posttraumatic stress disorder, schizophrenia, and substance dependence.
    Zhang H; Ozbay F; Lappalainen J; Kranzler HR; van Dyck CH; Charney DS; Price LH; Southwick S; Yang BZ; Rasmussen A; Gelernter J
    Am J Med Genet B Neuropsychiatr Genet; 2006 Jun; 141B(4):387-93. PubMed ID: 16649215
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.